Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Gross Margin (2016 - 2026)

Mimedx's Gross Margin history spans 16 years, with the latest figure at 70.56% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 1067.0% to 70.56% in Q1 2026 year-over-year; TTM through Mar 2026 was 81.04%, a 90.0% decrease, with the full-year FY2025 number at 82.56%, down 22.0% from a year prior.
  • Gross Margin hit 70.56% in Q1 2026 for Mimedx, down from 83.86% in the prior quarter.
  • Over the last five years, Gross Margin for MDXG hit a ceiling of 84.67% in Q1 2024 and a floor of 70.56% in Q1 2026.
  • Historically, Gross Margin has averaged 81.85% across 5 years, with a median of 82.32% in 2022.
  • Biggest five-year swings in Gross Margin: soared 338bps in 2023 and later plummeted -1067bps in 2026.
  • Tracing MDXG's Gross Margin over 5 years: stood at 80.68% in 2022, then increased by 4bps to 84.06% in 2023, then fell by -3bps to 81.8% in 2024, then increased by 3bps to 83.86% in 2025, then decreased by -16bps to 70.56% in 2026.
  • Business Quant data shows Gross Margin for MDXG at 70.56% in Q1 2026, 83.86% in Q4 2025, and 83.54% in Q3 2025.